Elbit Imaging Ltd. Announces Second Quarter Result... (----------------------- ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Elbit Imaging Ltd. Announces Second Quarter Results for 2008

Date:8/31/2008

-----------------------

Total

amount

Loans to attribut-

employees able to Total

to acquire share- share-

Gross Treasury Company holders of Minority holders'

Amount stock Shares the Company Interest equity

Convenience translation US$'000

----------------------------------------------------------

December 31,

2007 649,563 (41,324) (1,009) 607,230 356,075 963,306

Gain for

the period (3,458) - - (3,458) 19,110 15,652

Differences

from translation

of foreign

entities'

financial

statements (93,345) - - (93,345) (25,816) (119,161)

Dividend paid (50,138) - - (50,138) - (50,138)

Issuance of

shares to

the minority

by a

subsidiary - - - - 1,944 1,944

Repayment of

loans as

a result of the

realization by

employees of

rights to shares - - 1,014 1,014 - 1,014

Change in fair

value of Swap

transactions 4,574 - - 4,574 - 4,574

Stock based

compensation

expenses 2,024 - - 2,024 7,119 9,142

Dividend to the

minority - - - - (29,166) (29,166)

Employee share

premium 5 - (5) - - -

----------------------------------------------------------

June 30, 200
'/>"/>

SOURCE Elbit Imaging Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine news :

1. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
2. Elbit Medical Imaging Ltd. Announces Adjournment of its Annual General Meeting
3. Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing
4. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
5. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
6. Elbit Imaging Ltd. Announces First Quarter Results for 2008
7. Brain imaging reveals breakdown of normal emotional processing
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. Fry Construction Selected for High-Profile Medical Imaging Project
10. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
11. Imaging Software Helps Track, Treat Injured Brains

Post Your Comments:

(Date:12/16/2009)... ARBOR, Mich., Dec. 16 The most widely used ... finding that raises social justice questions that must be ... from stem cell advances, according to a University of ... of its kind, the U-M team analyzed 47 embryonic ... used by stem cell researchers. The scientists determined the ...

(Date:12/16/2009)... seven that increase susceptibility to disease , , WEDNESDAY, ... with increased susceptibility to leprosy have been identified ... researchers, who analyzed more than 10,000 DNA samples ... said their discovery highlights the important role that ... of leprosy. , "Though leprosy is not common, ...

(Date:12/16/2009)... Fla. University of Florida researchers at work on ... first to predict the spread of the disease using ... 21 million calls to determine how often residents of ... composed of two islands off the coast of Tanzania ... recent years. Its government commissioned the study as part ...

(Date:12/16/2009)... time in half, but use in humans is still far ... improve on nature, researchers have built and tested synthetic versions ... trauma or other cases where blood just won,t stop flowing. ... is used in degradable stitches, which dissolve in the body," ... Case Western Reserve University, and lead author of a report ...

(Date:12/16/2009)... annual marketing campaign , ... Englewood, ... 2010 Genetown™ Hotbed Campaign as its largest yearly promotion ... by MassBio and showcases 37 Massachusetts companies across ... entity’s brand on an electronic and printed map ...

Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5 Health News:Leprosy Genes Identified 2 Health News:Scientists use cell phone records to predict spread of malaria 2 Health News:Scientists use cell phone records to predict spread of malaria 3 Health News:Synthetic Platelets Put the Brakes on Blood Loss 2 Health News:Synthetic Platelets Put the Brakes on Blood Loss 3 Health News:Thriving Bioscience Region Leaves Its Mark 2

[0] U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines [0] Leprosy Genes Identified [0] Scientists use cell phone records to predict spread of malaria [0] Synthetic Platelets Put the Brakes on Blood Loss [0] Thriving Bioscience Region Leaves Its Mark

... Ohio Research here shows that an obscure form of ... play an important role in human cancer. , These ... researchers, but a new report in the September issue of ... the case. , The study found that UCRs, like ...

... has rescue workers, medical experts frustrated , , TUESDAY, Sept. ... of the Sept. 11, 2001, World Trade Center disaster ... , First, workers inhaled a toxic cocktail of soot, ... 12-hour shifts that lasted for weeks. There was also ...

... Executive Vice President, Corporate Development and, ... PRINCETON, N.J., Sept. 11 Pharmacopeia,(Nasdaq: ... development of novel,small molecule therapeutics, today announced the ... Corporate Development and S. David,Kimball, Ph.D., as Senior ...

... Vista Partners announced today,that it has updated coverage ... Director of Research for Vista Partners stated, "Tapestry,s,lead ... We were,particularly encouraged by activity in patients with ... for use in this difficult to treat,cancer." Vista ...

... China,Bionanometer Industries Corporation (OTC Pink Sheets: CBIU), a ... a new,series of biological nanometer cosmetics products named ... and experiments. The,name comes from the Italian word ... means -- "One,s Dreams Coming True." The ...

... PORT WASHINGTON, N.Y., Sept. 10 National,Medical Health Card ... benefit manager ("PBM"), today reported its results for the ... Three months ended June 30, 2007 Revenue ... as,compared to revenue of $211.5 million for the same ...

New class of RNA molecules may be important in human cancer 6 Years Later, 9/11 Health Questions Linger Pharmacopeia Announces Senior Additions to Management Team Vista Partners Updates Coverage on Tapestry Pharmaceuticals China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

(Date:12/16/2009)... N.Y., Dec. 16 BioSpecifics Technologies Corp. ... first in class collagenase-based products, today announced top-line ... clinical trial of XIAFLEX(TM) for the treatment of ... presence of inelastic collagen on the shaft of ... make sexual intercourse difficult or impossible in advanced ...

(Date:12/16/2009)... 16 Vivakor, Inc. (OTC Bulletin ... agreement with Baker Consulting out of Walnut ... Group, Inc. out of South Florida. ... to assist with business development, financing and ... acquisition strategy. Specifically, Baker Consulting is exploring ...

(Date:12/16/2009)... -- Naurex Inc., a new clinical stage company ... disorders based on its novel GFPA NMDA receptor ... Phase I clinical trial of its lead compound ... in the study. GLYX-13, a glycine site ... NMDA receptor, is initially being developed as a ...

Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4 Vivakor Signs Business Development Agreement With Baker Consulting 2 Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2 Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3 Hoarseness predominates in vocal health issues for inner city children 58831 1 Designing drugs and their antidotes together improves patient care 58829 1 Designing drugs and their antidotes together improves patient care 58829 2 Designing drugs and their antidotes together improves patient care 58829 3 Global death toll 3A 1 million premature babies every year 58827 1 Global death toll 3A 1 million premature babies every year 58827 2 Global death toll 3A 1 million premature babies every year 58827 3 Global death toll 3A 1 million premature babies every year 58827 4

[0] BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease [0] Vivakor Signs Business Development Agreement With Baker Consulting [0] Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression

... - ZIOPHARM Oncology, Inc.,(NASDAQ: ZIOP) announced today that ... the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference on ... the Mandarin Oriental Hotel, New York. Dr. Lewis,will ... update on its,clinical development programs., The presentation will ...

... -- Micromet,Inc. , a biopharmaceutical company focusing on ... inflammatory,and autoimmune diseases, today announced that Dr. Christian ... will,present at the 3rd Annual C.E. Unterberg, Towbin ... 12, 2007 at 10:00am,eastern. , A webcast of ...

Other Medicine Technology:ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2 Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference 2

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference

Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...

PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...

Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...

... The Johns Hopkins University Dermatology, ... Laboratory is a federally-(Clinical Laboratory Improvement ... that began operation in 1982. Its ... quality diagnostic allergy and immunology testing ...

Medicine Products:

Histopathology Reference Laboratory PhenoPath Laboratories LabCorp Dermatology, Allergy and Clinical Immunology (DACI) Reference Laboratory

Elbit Imaging Ltd. Announces Second Quarter Result...(----------------------- ...),Health